Caxton Associates (UK)’s Hologic HOLX Stock Holding History

Caxton Associates (UK)’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-515,637	Closed	-$39M	–	851
2026 Q1	$39M	Buy	+515,637	New	+$38.8M	0.88%	24
2025 Q4	–	Sell	-3,503	Closed	-$236K	–	844
2025 Q3	$236K	Buy	+3,503	New	+$233K	0.01%	602

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caxton Associates (UK)'s HOLX Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Hologic (HOLX) in Q2 2026, closing a stake of 515,637 shares — an estimated $39M sold.

Caxton Associates (UK) first reported a position in HOLX in Q3 2025 and held it in 2 quarters. The position peaked at $39M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Caxton Associates (UK) reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Caxton Associates (UK) sold 515,637 Hologic shares in Q2 2026, an estimated $39M.
Caxton Associates (UK) first reported a position in Hologic in Q3 2025 and held it in 2 quarters.
Caxton Associates (UK)'s Hologic position peaked at $39M in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.